Cancer News and Research

Latest Cancer News and Research

ASD children appear to outgrow critical social communication disability

Scientists at Albert Einstein College of Medicine of Yeshiva University have shown that high-functioning autism spectrum disorder (ASD) children appear to outgrow a critical social communication disability. Younger children with ASD have trouble integrating the auditory and visual cues associated with speech, but the researchers found that the problem clears up in adolescence.

29 Aug 2013

Study points to potential new therapeutic target for preventing birth defects in women with diabetes

A research team at the University of Maryland School of Medicine has identified a cell signaling pathway which plays a significant role in causing developmental defects of the fetal spinal cord and brain in babies of women with diabetes.

29 Aug 2013

Research links increased breast cancer risk to more alcohol drinking before motherhood

Here's a sobering fact for millions of young women heading back to school: The more alcohol they drink before motherhood, the greater their risk of future breast cancer.

29 Aug 2013

Tumor vessel density linked to mRCC treatment response

Changes in tumor vessel density correlate with response and resistance to anti-angiogenic therapy in patients with metastatic renal cell carcinoma, study findings suggest.

28 Aug 2013

Muscle density improves mRCC prognosis prediction

Patients with metastatic renal cell carcinoma treated with targeted therapies have a better prognosis if they also have a high quality of muscle, study findings indicate.

28 Aug 2013

Time to RCC recurrence prognostic threshold challenged

A large study confirms the prognostic value of time to recurrence after surgery for renal cell carcinoma, and also suggests the need to reduce the threshold for early recurrence.

28 Aug 2013

Findings support partial nephrectomy for T1b RCC

Partial nephrectomy and radical nephrectomy provide comparable cancer control for T1b renal cell carcinoma, yet use of the less radical approach has remained limited in the USA over recent years, study results show.

28 Aug 2013

Teva Declines Right To License Rexahn Cancer Drug

...

28 Aug 2013

Tumor Suppressor May Actually Drive Cancer Development

...

28 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

Researchers suggest new therapeutic target for brain tumor

Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas — the most common form of brain tumor — suggesting a new target for therapies for a cancer that does not respond to current chemotherapy.

28 Aug 2013

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Cepheid today announced the U.S. Food & Drug Administration has categorized Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments.

28 Aug 2013

Institut Curie's Emmanuel Barillot receives Agilent Thought Leader Award

Agilent Technologies Inc. today announced that Dr. Emmanuel Barillot, director of Bioinformatics and Systems IT at the Institut Curie in Paris, has received an Agilent Thought Leader Award in recognition of his pioneering development of user-friendly, Web-based bioinformatics tools for systems toxicology.

28 Aug 2013

URI professor studies rare hereditary disorder Fanconi anemia in children

When 2-year-old Logan Stevenson served as best man at his parents' wedding just days before he died of a rare genetic disorder, it drew international attention to a disease about which few people had ever heard. Hearing about Logan's story added another level of urgency to the research being conducted by University of Rhode Island Associate Professor Niall Howlett.

28 Aug 2013

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center G-ttingen and Chronix Biomedical, a molecular diagnostics company, the new method uses Bio-Rad Laboratories' Droplet Digital PCR (ddPCR-) technology to overcome the obstacles of earlier tests, which were both time-consuming and costly.

28 Aug 2013

Study shows ABL kinases have enhanced expression and activity in CML

Chronic Myelogenous Leukemia (CML) is a cancer of the white blood cells that is most commonly found in adults and in the elderly. Its incidence has been estimated to be 1 to 2 in 100,000 people. CML was the first cancer to be associated with a genetic abnormality, known as the Philadelphia Chromosome, which 95% of all CML patients carry in their cells.

28 Aug 2013

Viewpoints: Sen. Cruz's strategy and a looming deadline; Michigan republicans face key test

Mr. Cruz also acknowledged that he does "not have the votes right now" to force a shutdown. At least 41 Senators need to play along, and, so far, only 13 have signaled their commitment to the cause. But the senator would only go so far in accepting reality.

28 Aug 2013

Memorial Sloan-Kettering Cancer Center announces new on-site broadcast studio and pressroom

Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.

28 Aug 2013

USF professor studies ethics of RCT and efficacy in outcomes of new treatments

University of South Florida Distinguished Professor Benjamin Djulbegovic, MD, PhD, has studied the ethics of randomized clinical trials and their effectiveness in evaluating the outcomes of new treatments for decades.

28 Aug 2013

Funds to support study of telephone-based treatment program for lung cancer patients

An assistant professor of psychology in the School of Science at IUPUI will apply nearly $1 million in recently approved grants to study how a telephone-based treatment process can help ease stress and anxiety issues experienced by advanced-stage lung cancer patients and the family members who care for them.

28 Aug 2013

Cancer News and Research

Latest Cancer News and Research

ASD children appear to outgrow critical social communication disability

Study points to potential new therapeutic target for preventing birth defects in women with diabetes

Research links increased breast cancer risk to more alcohol drinking before motherhood

Tumor vessel density linked to mRCC treatment response

Muscle density improves mRCC prognosis prediction

Time to RCC recurrence prognostic threshold challenged

Findings support partial nephrectomy for T1b RCC

Teva Declines Right To License Rexahn Cancer Drug

Tumor Suppressor May Actually Drive Cancer Development

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Researchers suggest new therapeutic target for brain tumor

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Institut Curie's Emmanuel Barillot receives Agilent Thought Leader Award

URI professor studies rare hereditary disorder Fanconi anemia in children

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

Study shows ABL kinases have enhanced expression and activity in CML

Viewpoints: Sen. Cruz's strategy and a looming deadline; Michigan republicans face key test

Memorial Sloan-Kettering Cancer Center announces new on-site broadcast studio and pressroom

USF professor studies ethics of RCT and efficacy in outcomes of new treatments

Funds to support study of telephone-based treatment program for lung cancer patients

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in